Benjamin Edwards’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.67M Buy
22,171
+18,940
+586% +$3.8M 0.04% 363
2026
Q2
$614K Sell
3,231
-12,654
-80% -$2.17M 0.01% 979
2026
Q1
$2.68M Buy
15,885
+4,160
+35% +$711K 0.03% 467
2025
Q4
$1.98M Buy
11,725
+10,305
+726% +$1.67M 0.02% 505
2025
Q3
$205K Buy
+1,420
New +$194K ﹤0.01% 1241
2025
Q2
– Sell
-1,608
Closed -$206K – 1181
2025
Q1
$206K Sell
1,608
-91
-5% -$12.3K ﹤0.01% 1044
2024
Q4
$225K Buy
1,699
+20
+1% +$2.81K ﹤0.01% 1050
2024
Q3
$244K Buy
+1,679
New +$243K ﹤0.01% 1013
2022
Q4
– Sell
-35
Closed -$4K – 743
2022
Q3
$4K Sell
35
-948
-96% -$118K ﹤0.01% 624
2022
Q2
$116K Sell
983
-177
-15% -$21K 0.03% 325
2022
Q1
$151K Buy
1,160
+116
+11% +$15.1K 0.04% 303
2021
Q4
$159K Buy
1,044
+151
+17% +$23.4K 0.05% 290
2021
Q3
$144K Sell
893
-17
-2% -$2.86K 0.09% 204
2021
Q2
$149K Buy
910
+54
+6% +$8.32K 0.1% 184
2021
Q1
$129K Buy
856
+35
+4% +$5.56K 0.1% 185
2020
Q4
$124K Sell
821
-95
-10% -$13.6K 0.1% 176
2020
Q3
$124K Sell
916
-22
-2% -$2.98K 0.1% 155
2020
Q2
$128K Buy
938
+11
+1% +$1.4K 0.11% 140
2020
Q1
$100K Buy
+927
New +$107K 0.1% 141

Other funds holding IBB

Benjamin Edwards's IBB Position: Q3 2026 in Review

Benjamin Edwards increased its iShares Biotechnology ETF (IBB) stake by 586% in Q3 2026, buying an estimated $3.8M and bringing the position to 22,171 shares worth $4.67M. The position accounts for 0.04% of the portfolio, ranked #363.

Benjamin Edwards first reported a position in IBB in Q1 2020 and has held it in 19 quarters since. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Benjamin Edwards held 22,171 shares of iShares Biotechnology ETF worth $4.67M as of Q3 2026.
  • Benjamin Edwards bought 18,940 iShares Biotechnology ETF shares in Q3 2026, an estimated $3.8M.
  • iShares Biotechnology ETF made up 0.04% of Benjamin Edwards's portfolio in Q3 2026, its #363 holding.
  • Benjamin Edwards first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 19 quarters since.
  • 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.